Nicholas Veomett, Ph.D.

VP, Corporate Development, AlloNK Program Lead

Nicholas Veomett, Ph.D., has over a decade of experience in life sciences strategy and corporate development. Dr. Veomett joined Artiva in 2021 as Senior Director of Corporate Development. Prior to joining Artiva, he was Director of Corporate Development at Vividion Therapeutics, where he assisted in multiple private financings and a $135M-upfront collaboration with Roche. Prior to Vividion, Dr. Veomett was an Engagement Manager in the pharmaceuticals practice at McKinsey & Company. He completed a Ph.D. in pharmacology at Weill Cornell Medical College, with thesis work at Sloan Kettering Institute focused on antibody discovery and cancer immunotherapy. While at Cornell, he also founded the BioVenture eLab to launch and accelerate biotech and med tech startups. Dr. Veomett also holds a B.S. in biochemistry from the University of Arizona.